Mechanism Deep Dive · Respiratory Diseases

How the nasal spray platform repairs respiratory immune microenvironments

This category covers asthma / airway hyperreactivity, viral infection and sequelae, pulmonary fibrosis, and COPD / emphysema. The goal is not single-point anti-inflammation, but rebuilding immune thresholds, restoring barriers, reducing aberrant fibrosis, and improving metabolic resilience across the airway and alveolar microenvironment.

Th1 / Th2 Rebalance

Constitution-level immune correction for asthma and airway hyperreactivity

NF-kB / NLRP3

Inflammatory pathway de-noising before cytokine storm formation

Alveolar-Capillary Barrier

Repairs the oxygenation interface injured by viral and chronic inflammation

Anti-fibrosis + Regeneration

Balances fibroblast braking with alveolar regenerative support

Four Core Mechanistic Tracks

Complete mechanism map for respiratory diseases

The four tracks below correspond to four representative indication clusters while sharing the same underlying logic of immune-intensity shaping plus tissue-microenvironment repair.

Asthma / Airway Hyperreactivity

Correcting Th1 / Th2 imbalance and increasing Treg regulatory weight

This cluster reflects an alarm system stuck in a highly combustible state. The engineered signaling module reduces excessive Th2 bias, increases Treg-linked tolerance signaling, and combines this with mucosal barrier restoration so the airway is less likely to overreact to cold air, pollen, or particle exposure.

Th2 downTreg upAirway threshold resetLower hyperreactivity

Viral Infection & Sequelae

Shaping immune-response intensity and calming pre-storm inflammatory states

Exosomes are designed to penetrate injured regions and intervene at key nodes such as NF-kB / NLRP3 before full cytokine-storm escalation occurs. At the same time, they support alveolar-capillary barrier repair, mitochondrial metabolism, and oxygenation recovery to shorten convalescence and reduce long-term damage.

NF-kB / NLRP3Pre-storm interventionAlveolar repairMitochondrial support

Pulmonary Fibrosis (IPF)

Simultaneously controlling progression while repairing existing damage

The platform aims to shut down persistently active pro-inflammatory signaling that drives ongoing immune attack on lung tissue, while also reducing fibroblast activation and creating a more permissive window for alveolar regenerative support, controlling fibrotic progression while addressing existing structural damage.

Pro-inflammatory shutdownFibroblast controlAlveolar regenerationImproved oxygenation

COPD / Emphysema

Applying brakes to chronic inflammation while restoring structural and metabolic resilience

The priority is to reduce chronic airway exudation, improve microcirculation and epithelial repair, and strengthen local resilience through better mitochondrial energy metabolism. The objective is not unrealistic full reversal of all structural pathology, but fewer exacerbations and improved breathlessness, fatigue, and quality of life.

Inflammation brakingBetter microcirculationMitochondrial boostFewer exacerbations

Category Summary

Unified platform logic across respiratory diseases

This summary supports the category-level explanation after card click, showing that while the diseases differ, they all map to the same platform goal of immune-threshold rebuilding.

The shared mechanistic basis across respiratory diseases is to reshape the local respiratory immune-response intensity curve using functional T-cell-derived regulatory cytokine groups and miRNA clusters, reducing four key risks without bluntly suppressing host defense: Th2 bias, persistent inflammatory amplification, aberrant fibrosis, and metabolic exhaustion. Synthetic biology exosomes then carry these programs into airway and alveolar lesions to support epithelial and alveolar-capillary barrier repair, oxygenation, and mitochondrial function — shifting management from isolated flare control toward long-term immune-microenvironment restoration.

Back to Nasal Spray Research

Continue

Explore cardiopulmonary-axis or CNS disease mechanisms

All three categories share the same exosome delivery platform while diverging in barrier-crossing strategy, homing logic, and microenvironment-repair goals.

Cardiopulmonary-Axis Diseases CNS Diseases